NATCO Pharma
NATCOPHARM
NATCO Pharma Market Sentiment
| Timeline | Returns | Volume |
|---|---|---|
| Daily | - | 3,32,388 |
| Weekly | 10.08% | 29,28,516 |
| Monthly | 16.52% | 1,39,87,781 |
NATCO Pharma Performance
| Timeline | Daily | Weekly | Monthly |
|---|---|---|---|
| NATCOPHARM | - | 10.08% | 16.52% |
| Index | - | - | - |
| Peer Avg. | - | 5.43% | 11.51% |
NATCO Pharma Fundamentals
| Timeline | PE | PB | EV/EBIDTA | ROE | ROCE | Div. Yield |
|---|---|---|---|---|---|---|
| NATCOPHARM | 90.33 | 3.27 | 14.49 | 3.72 | 4.32 | 0.81 |
| Index | 35.44 | 5.98 | 16.81 | 16.99 | 18.41 | 1.19 |
| Peer Avg. | 39.55 | 4.75 | 12.35 | 13.59 | 17.02 | 0.87 |
NATCO Pharma Key Metrics
| Metrics | Sales Growth | Profit Growth | ROE | ROCE |
|---|---|---|---|---|
| FY '21-22 | 0.84% | -58.31% | 3.72% | 4.32% |
| FY '20-21 | -0.24% | -19.10% | 9.54% | 11.72% |
| FY '19-20 | -9.22% | -28.78% | 12.79% | 14.83% |
NATCO Pharma Shareholding Pattern
NATCO Pharma Profit & Loss
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| FY '21-22 | 1,856.30 | 1,618.05 | 335.05 | 154.55 |
| FY '20-21 | 1,852.80 | 1,343.30 | 614.25 | 375.95 |
| FY '19-20 | 1,852.60 | 1,272.30 | 695.90 | 466.30 |
NATCO Pharma Peer Comparison
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| NATCOPHARM | 1,856.30 | 1,618.05 | 335.05 | 154.55 |
| ERIS | 1,281.39 | 796.85 | 512.08 | 411.49 |
| APLLTD | 5,170.59 | 4,279.13 | 942.28 | 529.60 |
NATCO Pharma Share Price
Natco Pharma Limited is a vertically integrated R&D pharmaceutical company based in India. The company's field of activity is the pharmaceutical business, which includes research and development, production and sale of bulk drugs and ready-made medical preparations. The company produces ready-to-use dosage forms (FDFs), which it sells in India, the US and the rest of the world, and also produces active pharmaceutical ingredients (APIs). Its capabilities include multi-step synthesis, semi-synthetic splicing technologies, production of potent APIs and peptides. The company operates in two segments: Pharmaceuticals and Agricultural Chemicals. In the pharmaceutical industry, the Company channels its sales through FDFs and APIs. The agrochemicals segment focuses on specialty products, including pest control.